Search - tctmd.com

Displaying 1 - 20 of 30

Sort: Relevancy | Date

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Opinion Editor's Corner

ISCHEMIA Questions? Some Answers From David Maron

Shelley Wood

December 09, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2019

Shelley Wood

November 29, 2019

News Daily News

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Michael O'Riordan

November 29, 2019

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

News Conference News AHA 2019

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

Todd Neale

November 18, 2019

News Conference News AHA 2019

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

Todd Neale

November 16, 2019

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Opinion Off Script AHA 2019

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

Ajay Kirtane, MD, SM

November 12, 2019

News Conference News TCT 2019

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Todd Neale

October 03, 2019

Presentation TCT Abstracts Posters 2019

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Presenter: Yuichi Ozaki

September 29, 2019

News

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

Michael O'Riordan

September 24, 2019

News Conference News ESC 2019

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Yael L. Maxwell

September 10, 2019

News Conference News ESC 2019

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

Shelley Wood

September 01, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

Shelley Wood

August 05, 2019

Presentation CHIP Seattle 2019

CHIP 2.0:Where We Need to Go Next

Presenter: Ajay J. Kirtane

August 03, 2019

News Industry News

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

July 15, 2019

Presentation SCCT 2019

Latest Insights From SCOT-HEART Sub-studies

Presenter: David Newby

July 11, 2019

Advertisement

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

ISCHEMIA Questions? Some Answers From David Maron

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

TCTMD’s Top 10 Most Popular Stories for November 2019

Uninformed Consent? Most Patients Misunderstand True Benefits of PCI

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

EVAPORATE Hints at Slowed Plaque Progression With Icosapent Ethyl

ISCHEMIA-CKD: Routine Invasive Approach No Help in CKD Patients With Stable CAD

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Off Script: Will ISCHEMIA Answer Our Most Pressing Questions?

TICAKOREA: Ticagrelor Ups Bleeding Over Clopidogrel in Korean ACS Patients

Distribution of coronary artery disease in patients with low-risk transcatheter aortic valve replacement: A computed tomography coronary angiography study (from the LRT trial)

Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia

GRACE Risk Tool Fails to Increase Use of Guideline-Based Care After ACS: AGRIS

Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Best Strategy Questioned for NSTE ACS Patients With Prior CABG

CHIP 2.0:Where We Need to Go Next

FDA approves Bayer's Gadavist® (gadobutrol) injection as the first and only contrast agent for use in cardiac MR in adult patients with known or suspected coronary artery disease

Latest Insights From SCOT-HEART Sub-studies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content